Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 3

Sponsor Class

NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Sarcoma 2

Conditions

Wilms Tumor 3Beckwith-Wiedemann Syndrome 1

Interventions

Magnetic Resonance Spectroscopy 44Specimen Handling 38enzalutamide 30Nivolumab 30pembrolizumab 28Docetaxel 23Gemcitabine 22apalutamide 20Prednisone 20Biopsy 20Abiraterone Acetate 18Androgen Antagonists 17cabozantinib 14darolutamide 13abiraterone 13Radiotherapy 13Cisplatin 12enfortumab vedotin 11Radiation 11Ipilimumab 11Pluvicto 10erdafitinib 9belzutifan 9atezolizumab 9X-Rays 9Radiosurgery 9Mitomycin 9olaparib 8cabazitaxel 8Standard of Care 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Dactinomycin × Genitourinary × 30 days × Clear all
NCT00352534 2026-06-03

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor

Children's Oncology Group

Phase 3 Completed
808 enrolled 11 charts
Genitourinary

Wilms Tumor

NCT00379340 2026-06-03

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

Children's Oncology Group

Phase 3 Completed
395 enrolled 15 charts
Genitourinary

Wilms Tumor

NCT00945009 2026-06-03

Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

Children's Oncology Group

Phase 3 Completed
249 enrolled 14 charts
Genitourinary

Beckwith-Wiedemann Syndrome, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡